NFB-28585-20457
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 121 / NY
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-25
- 2020-12-27
- 2020-12-30
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Survey response — day 0, dose 2MedDRA: Pregnancy — Feeling: Good · Site: PainFree text: Currently pregnant 6/7weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-04
Survey response — day 21, dose 2MedDRA: Alopecia areata — Feeling: GoodFree text: Focal alopecia areata which has recurred. May not be related to vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Call successfulDoes not wish to fill out VAERS report
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2022-01-12
Survey response — 12 months, dose 2MedDRA: Adverse drug reaction, Mastitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mastitis Serum sickness secondary to penicillinMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-14
-
2022-01-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 1 — day 0, dose 2
Systemic reaction (other): Currently pregnant 6/7weeks
Release 3 — day 21, dose 2
Symptoms: Focal alopecia areata which has recurred. May not be related to vaccine
Release 10 — 12 months, dose 2
Symptoms: Mastitis Serum sickness secondary to penicillin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Alopecia areata | ✓ | ✓ | ✓ |
| SD | Mastitis | · | · | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release